Literature DB >> 11812415

Reactivation of histoplasmosis after treatment with infliximab.

Masha Nakelchik, Julie E Mangino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11812415     DOI： 10.1016/s0002-9343(01)00945-7

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  16 in total

1.  Whole-body deletion of LPS-induced TNF-α factor (LITAF) markedly improves experimental endotoxic shock and inflammatory arthritis.

Authors:  Jamie C Merrill; Jian You; Cara Constable; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

Review 2.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

Review 3.  Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.

Authors:  Nirmal Kaur; Thomas C Mahl
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 4.  Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of tumour necrosis factor-alpha antagonist therapy in Crohn's disease.

Authors:  D C Sadowski; C N Bernstein; A Bitton; K Croitoru; R N Fedorak; A Griffiths
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

5.  Inflammatory bowel disease in travelers: choosing the right vaccines and check-ups.

Authors:  Maria Esteve; Carme Loras; Ester García-Planella
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

6.  Antifungal therapeutics for dimorphic fungal pathogens.

Authors:  Kristie D Goughenour; Chad A Rappleye
Journal:  Virulence       Date:  2016-09-19       Impact factor: 5.882

7.  Molecular evidence of recurrent histoplasmosis with 9-year latency in a patient with Addison's disease.

Authors:  Tai-Chung Tseng; Shwu-Jen Liaw; Cheng-Hsiang Hsiao; Cheng-Yi Wang; Li-Na Lee; Tien-Shang Huang; Po-Ren Hsueh
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

Review 8.  Biologic treatments for systemic rheumatic diseases.

Authors:  Y Shirota; G G Illei; N P Nikolov
Journal:  Oral Dis       Date:  2008-02-14       Impact factor: 3.511

9.  Listeria meningitis complicating infliximab treatment for Crohn's disease.

Authors:  Geoffrey Williams; Asad A Khan; Franzjosef Schweiger
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

10.  The Development of Novel Therapies for Rheumatoid Arthritis.

Authors:  Ling-Dong Quan; Geoffrey M Thiele; Jun Tian; Dong Wang
Journal:  Expert Opin Ther Pat       Date:  2008-07       Impact factor: 6.674
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.